Ķazaķstannyṇ Klinikalyķ Medicinasy (Jun 2021)

Radiofrequency ablation of renal allograft cancer: Case report

  • Jamilya Saparbay,
  • Saitkarim Abdugafarov,
  • Melss Assykbayev,
  • Abylaikhan Sharmenov,
  • Aygerim Kalzhan

DOI
https://doi.org/10.23950/jcmk/10927
Journal volume & issue
Vol. 18, no. 3
pp. 62 – 64

Abstract

Read online

Abstract Renal cell carcinoma (RCC) of an allograft kidney is an extremely rare type of neoplasm and accounts for about 0.22-0.5% of all kidney recipients. Kidney recipients undergo routine check-up, including ultrasound examination of the graft. RCC is often asymptomatic and can be an incidental finding on routine examination. In this case study, we describe a patient who developed clear cell carcinoma 9 months after the kidney transplantation from a living related donor. Radiofrequency ablation was chosen as the treatment option, considering small size solitary lesion in renal allograft. Complete ablative response was achieved after one treatment. In 4-year follow up period patient did not show any new or recurrent tumor. Radiofrequency ablation is a good therapeutic option for kidney allograft carcinoma.

Keywords